ARS Pharmaceuticals, Inc.
SPRY
$5.23
-$0.16-2.97%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -40.10% | -27.11% | -21.98% | 40.72% | 9.78% |
| Total Receivables | 82.65% | 186.76% | 187.16% | 2,942.29% | 4,712.18% |
| Inventory | 33.77% | 21.28% | 60.57% | 988.39% | -- |
| Prepaid Expenses | 86.97% | -37.79% | -11.76% | 197.13% | 366.91% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 84.66% | 307.85% |
| Total Current Assets | -24.85% | -19.29% | -14.78% | 62.30% | 27.50% |
|
|
|||||
| Total Current Assets | -24.85% | -19.29% | -14.78% | 62.30% | 27.50% |
| Net Property, Plant & Equipment | -20.99% | 99.22% | 131.24% | 183.21% | 237.47% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.62% | 89.22% | 96.07% | 88.57% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 35.49% | 74.60% | 206.84% | -- | 3,540.58% |
| Total Assets | -20.41% | -12.14% | -6.69% | 71.32% | 41.23% |
|
|
|||||
| Total Accounts Payable | -67.71% | -42.31% | -35.12% | 1.28% | 391.99% |
| Total Accrued Expenses | 153.09% | 115.43% | 306.35% | 242.77% | 248.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 471.57% | 268.13% |
| Total Finance Division Other Current Liabilities | 57.06% | 153.50% | 191.33% | 1,379.35% | 8,039.29% |
| Total Other Current Liabilities | 57.06% | 153.50% | 191.33% | 1,379.35% | 8,039.29% |
| Total Current Liabilities | 33.47% | 79.61% | 67.00% | 206.06% | 578.05% |
|
|
|||||
| Total Current Liabilities | 33.47% | 79.61% | 67.00% | 206.06% | 578.05% |
| Long-Term Debt | 138.47% | 146.74% | 142.88% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 79.17% | 307.47% | 274.35% | -- | -- |
| Total Liabilities | 95.61% | 130.07% | 126.16% | 1,254.44% | 1,701.50% |
|
|
|||||
| Common Stock & APIC | 9.05% | 7.89% | 7.60% | 7.24% | 6.77% |
| Retained Earnings | -106.58% | -125.90% | -138.92% | -46.20% | -31.16% |
| Treasury Stock & Other | -204.35% | -233.33% | -43.18% | -102.06% | 68.28% |
| Total Common Equity | -93.49% | -73.22% | -55.51% | -26.53% | -10.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -93.49% | -73.22% | -55.51% | -26.53% | -10.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -93.49% | -73.22% | -55.51% | -26.53% | -10.65% |
|
|
|||||